Mechanisms of Drug Desensitization: Not Only Mast Cells
Drug desensitization (DD) allows transient clinical tolerance to the drug in reactive patients and it is frequently and successfully used in the management of both IgE and non IgE-mediated hypersensitivity reactions (HRs). The underlying mechanisms behind this process is not well understood. The des...
Saved in:
Main Authors: | Alessandra Vultaggio (Author), Andrea Matucci (Author), Francesca Nencini (Author), Susanna Bormioli (Author), Emanuele Vivarelli (Author), Enrico Maggi (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer
by: Alessandra Vultaggio, et al.
Published: (2021) -
COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms
by: Robert W. Malone, et al.
Published: (2021) -
Effect of desensitizing toothpastes on dentin
by: Shelon Cristina Souza Pinto, et al.
Published: (2012) -
Influence of Mast Cells in Drug-Induced Gingival Overgrowth
by: Tamilselvan Subramani, et al.
Published: (2013) -
Opioid receptor desensitization: mechanisms and its link to tolerance
by: Stéphane eAllouche, et al.
Published: (2014)